EUVIMEDEUVIMED entdecken
Crossref

Discovery of a Novel HSP90-Targeting Inhibitor for AML from the Marine Aaptamine Scaffold

Haitao Xue, Hongrui Zhu, Shuai Liu, Yongtao Qian, Bin Cheng iD, Fan Sun, Hongze Liao iD, Houwen Lin iD

Journal of Medicinal Chemistry · 13.08.2026 · 69 (15) · 19107-19129

DOI: 10.1021/acs.jmedchem.6c01410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 28.07.2026. Verfasst von Haitao Xue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Ren Ji Hospital, College of Clinical Pharmacy, State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University Sc…. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Leukemia, Myeloid, Acute, Antineoplastic Agents. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to single-target therapies has spurred interest in multitarget strategies for acute myeloid leukemia (AML). Heat shock protein 90 (HSP90), a chaperone that stabilizes numerous oncogenic client proteins, represents an attractive therapeutic target for AML; however, the clinical development of early HSP90 inhibitors was limited by dose-limiting toxicities and an excessive heat-shock response (HSR). Through structural optimization of the marine aaptamine scaffold and target identification, ap-a48 was identified as a novel HSP90-targeting anti-AML lead that exhibits potent anti-AML activity and acceptable preliminary tolerability while inducing only a modest HSR. In rats, ap-a48 showed favorable pharmacokinetics with 65.3% oral bioavailability, and in HL-60 xenograft mouse models, it suppressed tumor growth (71.2% inhibition at intraperitoneal 40 mg/kg; 67.3% at oral 60 mg/kg) without significant hepatotoxicity or major organ abnormalities. These findings identify ap-a48 as a promising marine-natural-product-derived HSP90-targeting lead for AML therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HSP90 Heat-Shock ProteinsLeukemia, Myeloid, AcuteAntineoplastic AgentsAnimalsHumansRatsMiceStructure-Activity RelationshipHL-60 CellsDrug DiscoveryMaleXenograft Model Antitumor AssaysRats, Sprague-Dawley

Substanzen

HSP90 Heat-Shock ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Ren Ji Hospital, College of Clinical Pharmacy, State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai200127, China.
  • School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai200240, China.
  • School of Food and Drug-Institute of Marine Biomedicine, Shenzhen Polytechnic University, Shenzhen518000, China.
  • Integrated Innovation Center for Marine Drugs, Shanghai Jiao Tong University, Shanghai200240, China.
  • Marine Biomedical Science and Technology Innovation Platform of Lin-gang Special Area, Shanghai201306, China.

ORCID-Profile: Bin Cheng, Hongze Liao, Houwen Lin

Förderung

  • Innovative Research Team of High-level Local University in Shanghai
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
  • Natural Science Foundation of Shandong Province
  • National Key Research and Development Program of China
  • Lingang Special Area Marine Biomedical Innovation Platform

Zitieren

APA

Xue, H., Zhu, H., Liu, S., Qian, Y., Cheng, B., Sun, F., Liao, H., & Lin, H. (2026). Discovery of a Novel HSP90-Targeting Inhibitor for AML from the Marine Aaptamine Scaffold. Journal of Medicinal Chemistry, 69(15), 19107-19129. https://doi.org/10.1021/acs.jmedchem.6c01410

Vancouver

Xue H, Zhu H, Liu S, Qian Y, Cheng B, Sun F, et al. Discovery of a Novel HSP90-Targeting Inhibitor for AML from the Marine Aaptamine Scaffold. Journal of Medicinal Chemistry. 2026;69(15):19107-19129. doi:10.1021/acs.jmedchem.6c01410

BibTeX
@article{Xue2026,
  author = {Xue, Haitao and Zhu, Hongrui and Liu, Shuai and Qian, Yongtao and Cheng, Bin and Sun, Fan and Liao, Hongze and Lin, Houwen},
  title = {Discovery of a Novel HSP90-Targeting Inhibitor for AML from the Marine Aaptamine Scaffold},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {15},
  pages = {19107--19129},
  doi = {10.1021/acs.jmedchem.6c01410}
}
Kostenlos starten →